Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Bvf Inc/Il
Form 13F · Q2 2026

Bvf Inc/Il

CIK 1056807Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$3.9B
Reported book value
44
Positions
12
Quarters on record
Top 50
Positions

Bvf Inc/Il — holdings

Top 44 positions of 44, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1RVMD Revolution Medicines Inc3.0M+3.8%$555M14.2%
2KYMR Kymera Therapeutics Inc3.9M−29.6%$444M11.4%
3XOMA ROYALTY CORPORATION Xoma Royalty Corporation7.6M+193.1%$323M8.3%
4MLTX Moonlake Immunotherapeutics16.0M+0.0%$312M8.0%
5GHRS Gh Research Plc8.7M+0.0%$233M5.9%
6GPCR Structure Therapeutics Inc3.4M−2.7%$181M4.6%
7NKTR Nektar Therapeutics2.4M−6.6%$167M4.3%
8MIRM Mirum Pharmaceuticals Inc1.1M−33.4%$124M3.2%
9XNCR Xencor Inc7.1M+0.0%$115M2.9%
10ALKS Alkermes Plc2.2M+7.7%$113M2.9%
11GLUE Monte Rosa Therapeutics Inc4.5M+0.0%$108M2.8%
12CGEM Cullinan Therapeutics Inc5.8M+0.0%$105M2.7%
13PVLA Palvella Therapeutics Inc Ne672,789−30.0%$103M2.6%
14ZYME Zymeworks Inc3.6M−2.3%$95M2.4%
15KURA Kura Oncology Inc8.4M+0.0%$93M2.4%
16IRON Disc Medicine Inc1.2M−9.3%$84M2.2%
17STOK Stoke Therapeutics Inc2.5M+0.0%$83M2.1%
18OLEMA PHARMACEUTICALS INC Olema Pharmaceuticals Inc5.3M+0.0%$66M1.7%
19ANNX Annexon Inc8.7M+0.0%$50M1.3%
20CBIO Crescent Biopharma Inc.2.7M+0.0%$49M1.3%
21ACIU Ac Immune Sa19.8M+0.0%$47M1.2%
22TYRA Tyra Biosciences Inc1.5M−25.3%$47M1.2%
23STRO Sutro Biopharma Inc1.3M+0.0%$42M1.1%
24IMCR Immunocore Hldgs Plc1.3M+0.0%$41M1.1%
25AVTX Avalo Therapeutics Inc2.1M+27.1%$38M1.0%
26FDMT 4D Molecular Therapeutics In2.9M+0.0%$38M1.0%
27QTTB Q32 Bio Inc2.4M—$30M0.8%
28AVR Anteris Technologies Global3.0M+0.0%$30M0.8%
29FHTX Foghorn Therapeutics Inc5.8M+0.0%$29M0.7%
30ABSI Absci Corporation2.4M—$27M0.7%
31ELDN Eledon Pharmaceuticals Inc6.3M+0.0%$25M0.6%
32IVVD Invivyd Inc28.2M+44.3%$25M0.6%
33SGMT Sagimet Biosciences Inc2.5M—$19M0.5%
34OKUR Onkure Therapeutics Inc3.2M+63.5%$15M0.4%
35IMUX Immunic Inc765,295—$12M0.3%
36XFOR X4 Pharmaceuticals Inc2.2M+0.0%$10M0.3%
37IMA Imagenebio Inc1.1M+0.0%$7M0.2%
38TCRX Tscan Therapeutics Inc5.6M+0.0%$5M0.1%
39RACC Research Alliance Corp Iii500,000—$5M0.1%
40MOLN Molecular Partners Ag1.4M+0.0%$5M0.1%
41TENX Tenax Therapeutics Inc339,549+0.0%$5M0.1%
42ENTX Entera Bio Ltd2.4M—$4M0.1%
43IVA Inventiva Sa686,040+0.0%$3M0.1%
44ENGN Engene Therapeutics Inc945,402—$274,0720.0%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.